557 related articles for article (PubMed ID: 19152959)
1. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
3. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis with other idiopathic and secondary interstitial lung diseases.
Rossi G; Andreani A; Morandi P; Marchioni A; Corradini P; Cappiello G; Bortolotti M; Qosja A; Manzini C; Ferri C; Richeldi L; Cavazza A
Am J Clin Pathol; 2008 Dec; 130(6):927-33. PubMed ID: 19019770
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
[TBL] [Abstract][Full Text] [Related]
6. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
7. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of interstitial lung disease (ILD) in patients with systemic sclerosis. The significance of broncho-alveolar lavage (BAL) --personal observations].
Kopiński P; Korkosz M; Janowska E
Folia Med Cracov; 1996; 37(3-4):51-66. PubMed ID: 9312535
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
Vatrella A; Bocchino M; Perna F; Scarpa R; Galati D; Spina S; Pelaia G; Cazzola M; Sanduzzi A
Respir Med; 2007 Jul; 101(7):1383-9. PubMed ID: 17369033
[TBL] [Abstract][Full Text] [Related]
11. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
12. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
De Santis M; Bosello SL; Peluso G; Pinnelli M; Alivernini S; Zizzo G; Bocci M; Capacci A; La Torre G; Mannocci A; Pagliari G; Varone F; Pistelli R; Danza FM; Ferraccioli G
Clin Respir J; 2012 Jan; 6(1):9-17. PubMed ID: 21801327
[TBL] [Abstract][Full Text] [Related]
14. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-/polymyositis and systemic sclerosis.
Kumánovics G; Magyarlaki T; Komócsi A; Szekeres G; Czirják L
Rheumatol Int; 2003 Jan; 23(1):6-10. PubMed ID: 12548435
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage as a diagnostic tool.
Meyer KC
Semin Respir Crit Care Med; 2007 Oct; 28(5):546-60. PubMed ID: 17975782
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage in idiopathic interstitial lung diseases.
Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T
Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]